Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

CATX Relative to the S&P 500

CATX Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Perspective Therapeutics Inc. (AMEX:CATX) seasonal charts above shows that a Buy Date of November 10 and a Sell Date of January 31 has resulted in a geometric average return of 15.88% above the benchmark rate of the S&P 500 Total Return Index over the past 19 years. This seasonal timeframe has shown positive results compared to the benchmark in 13 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 19 years by an average of 38.75% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various?treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

To download CATX seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: CATX